Migdal Insurance & Financial Holdings’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9M	Hold	770,909	–	–	0.12%	82
2025 Q4	$18.1M	Hold	770,909	–	–	0.16%	70
2025 Q3	$15.4M	Hold	770,909	–	–	0.17%	70
2025 Q2	$10.6M	Sell	770,909 -15,563	-2%	-$149K	0.13%	84
2025 Q1	$8.7M	Buy	786,472 +100,000	+15%	+$1.07M	0.12%	91
2024 Q4	$7.31M	Hold	686,472	–	–	0.1%	87
2024 Q3	$8.72M	Hold	686,472	–	–	0.14%	72
2024 Q2	$11.5M	Hold	686,472	–	–	0.19%	74
2024 Q1	$10.3M	Buy	686,472 +38,170	+6%	+$624K	0.16%	78
2023 Q4	$9.72M	Hold	648,302	–	–	0.2%	76
2023 Q3	$9.08M	Sell	648,302 -50,000	-7%	-$803K	0.19%	74
2023 Q2	$7.23M	Hold	698,302	–	–	0.17%	77
2023 Q1	$6.45M	Hold	698,302	–	–	0.14%	74
2022 Q4	$6.19M	Hold	698,302	–	–	0.14%	72
2022 Q3	$5.81M	Hold	698,302	–	–	0.13%	79
2022 Q2	$5.72M	Hold	698,302	–	–	0.13%	76
2022 Q1	$6.08M	Hold	698,302	–	–	0.11%	93
2021 Q4	$6.64M	Hold	698,302	–	–	0.06%	123
2021 Q3	$11.7M	Hold	698,302	–	–	0.12%	110
2021 Q2	$10.7M	Hold	698,302	–	–	0.11%	118
2021 Q1	$13.6M	Sell	698,302 -40,000	-5%	-$849K	0.14%	122
2020 Q4	$13.3M	Hold	738,302	–	–	0.16%	97
2020 Q3	$14.2M	Hold	738,302	–	–	0.2%	100
2020 Q2	$19.3M	Hold	738,302	–	–	0.31%	71
2020 Q1	$13.2M	Hold	738,302	–	–	0.31%	67
2019 Q4	$24.6M	Sell	738,302 -35,000	-5%	-$955K	0.47%	49
2019 Q3	$18.4M	Buy	773,302 +420,000	+119%	+$13.7M	0.38%	63
2019 Q2	$12.7M	Hold	353,302	–	–	0.32%	64
2019 Q1	$13.1M	Buy	+353,302	New	+$14.8M	0.31%	63